Morningstar's Genetic Signatures Ltd Stock Analysis
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Genetic Signatures Ltd's Company Profile
Genetic Signatures Ltd is a molecular diagnostics company. The company is engaged in the development and commercialization of its proprietary platform technology, 3Base. The firm operates under one business segment namely the research and commercialisation of identifying individual genetic signatures to identify diseases and disabilities. It offers various detection kits under the brand EasyScreen in order to detect different infectious diseases including gastroenteritis, respiratory diseases, meningitis pathogens, among others.
Sydney, NSW, 2042, Australia